Skip to main content
DR REDDYS LABORATORIES LTD logo

DR REDDYS LABORATORIES LTD — Investor Relations & Filings

Ticker · RDY ISIN · US2561352038 LEI · 335800OVDPY3DVZR2798 BSE.NS Manufacturing
Open in API
Filings indexed 2,316 across all filing types
Latest filing 2025-06-03 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS RDY

About DR REDDYS LABORATORIES LTD

https://www.drreddys.com/

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company focused on providing affordable and innovative medicines. The company's core activities include the development, manufacturing, and marketing of a broad portfolio of products. This portfolio encompasses Active Pharmaceutical Ingredients (APIs), generic and branded-generic formulations, over-the-counter (OTC) products, and biologics. In addition to its significant presence in the generics market, the company invests in the research and development of novel molecules and proprietary products, with a focus on therapeutic areas such as dermatology and neurology. Dr. Reddy's is also committed to sustainable operations, actively working to reduce its environmental footprint through initiatives in water conservation, waste reduction, and decarbonisation.

Recent filings

Filing Released Lang Actions
Allotment of stock options under Employee Stock options scheme
Share Issue/Capital Change Classification · 95% confidence The document is a formal disclosure addressed to multiple stock exchanges regarding the allotment of equity shares on exercise of stock options under the company's ESOP scheme. It references compliance with SEBI regulations, provides detailed information about the shares issued, exercise price, and other share details. The content is an announcement of a capital change event (allotment of shares due to stock options exercise) rather than a financial report, earnings release, or management discussion. The document length is about 6,315 characters, which is consistent with a detailed announcement but not a full financial report. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA).
2025-06-03 English
FORM 6-K
Regulatory Filings
2025-06-02 English
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges regarding a regulatory notice and order received from the Income Tax Authority related to reassessment of income for a past assessment year. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30, which pertains to material events or information disclosures. The content focuses on litigation and tax reassessment notices, with no financial statements or detailed financial analysis presented. The document is about a regulatory/legal update rather than a financial report or earnings release. It is not a full audit report or annual/interim report, nor is it a call transcript or investor presentation. The document is a regulatory announcement about a legal/tax matter, fitting best under Regulatory Filings (RNS). The document length (6350 characters) and content confirm it is not a brief announcement nor a full report but a regulatory disclosure under SEBI rules.
2025-05-31 English
Copies of Newspaper Publication
Annual Report Classification · 95% confidence The document contains detailed financial data including audited consolidated financial results for the quarter and year ended March 31, 2025, with figures for income, profit, equity share capital, and earnings per share. It references compliance with SEBI regulations and includes multiple companies' financial results. The presence of comprehensive financial statements and analysis for a full fiscal year indicates this is a full annual financial report. There is no indication that this is merely an announcement or a certification. Therefore, the document fits the definition of an Annual Report (10-K equivalent).
2025-05-30 English
Copies of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data including audited consolidated financial results for the quarter and year ended March 31, 2025, with figures for income, profit, and earnings per share. It references Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to quarterly and annual financial results disclosures. The presence of comprehensive financial tables and audited figures indicates this is a formal financial report rather than a brief announcement or certification. The document length is substantial (15,000 characters), and it includes actual financial statements and analysis for a fiscal year-end period. Therefore, this document fits the definition of an Interim / Quarterly Report (IR) as it covers quarterly and year-end financial results with substantive data, but it is not a full Annual Report (10-K) since it focuses on quarterly and year-end results rather than a full annual report narrative. The document also includes notes typical of quarterly financial disclosures.
2025-05-30 English
FORM 6-K
Regulatory Filings
2025-05-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.